Diabetes Tipo 2
Designed to evaluate the effectiveness of a new oral medication in controlling blood sugar levels in adults with Type 2 Diabetes who are already taking Metformin.
Requisitos de calificación
- Hombres y mujeres
- Edades de 18 a 75 años
- generally good health
- Diagnosticado con Diabetes Tipo 2
- Actualmente tomando Metformina
- Non-smoker or former smoker
- Not currently using insulin
COMPENSACIÓN: $3,000
Detalles del estudio
Designed to evaluate the effectiveness of a new oral medication in controlling blood sugar levels in adults with Type 2 Diabetes who are already taking Metformin. This study will consist of 17 outpatient visits, and 3 safety phone calls and has a duration of 4 months.
Designed to evaluate the effectiveness of a new oral medication in controlling blood sugar levels in adults with Type 2 Diabetes who are already taking Metformin. This study will consist of 17 outpatient visits, and 3 safety phone calls and has a duration of 4 months.